SIMABS
0732.709.096 · rovalta.com · 21/09/2026
ACTIVE
SIMABS
Financial year 2024 · closed on 31/12/2024
Net result
-986,9 k €
-117.8% YoY
Gross margin
-105,2 k €
-186.7% YoY
Equity
-337,0 k €
-151.9% YoY
Workforce
7,3 ETP
Overview
What does SIMABS do?
SIMABS is a Public limited company incorporated in 2019. Its registered office is in Diepenbeek. It employs on average 7,3 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0732.709.096
Incorporation
20/08/2019
Legal form
Public limited company
Registered office
Agoralaan Abis
3590 Diepenbeek · FlandreSee on map
3590 Diepenbeek · FlandreSee on map
Contributed capital
1 906 600,00 €
Latest accounts
31/12/2024
Average workforce
7,3 ETP
Joint committees (2)
- 207
- 20700
Contacts
2 public details availableLog in to view
Signals
Good liquidityHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 5 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -105,2 k € | -187% | 121,3 k € | +151% | -236,9 k € | -96.8% | -120,4 k € | -132% | 371,7 k € |
| EBITDA | -768,0 k € | -214% | -244,8 k € | +57.2% | -572,2 k € | -86.2% | -307,3 k € | -188% | 349,4 k € |
| Operating result | -964,0 k € | -121% | -436,2 k € | +41.4% | -744,4 k € | -108% | -358,2 k € | -203% | 348,3 k € |
| Net result | -986,9 k € | -118% | -453,2 k € | +41.0% | -768,1 k € | -107% | -370,8 k € | -211% | 335,4 k € |
| Balance sheet | |||||||||
| Equity | -337,0 k € | -152% | 649,8 k € | +139% | 271,4 k € | -73.9% | 1,0 M € | +24.4% | 835,4 k € |
| Total assets | 1,1 M € | -22.1% | 1,4 M € | +20.1% | 1,2 M € | -46.8% | 2,2 M € | +62.6% | 1,4 M € |
| Cash | 162,8 k € | -75.8% | 672,2 k € | +96.4% | 342,3 k € | -58.6% | 826,1 k € | -35.8% | 1,3 M € |
| Debts | 1,2 M € | +53.2% | 776,5 k € | -15.2% | 915,7 k € | -23.2% | 1,2 M € | +122% | 537,4 k € |
| Other | |||||||||
| Workforce | 7,3 ETP | – | 4,4 ETP | +46.7% | 3,0 ETP | +50.0% | 2,0 ETP | ||
Governance
Board of directors
Seen on filing of 31/12/2024 · 6 active · 12 ended
Active mandates
Active
Active
Active
Active
Active
Nicolas Vandermarliere
ActiveEnded mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
Bedal International● Active | 0841.685.826 |
BIOCLUE● Active | 0719.914.105 |
BIOKEY● Active | 0719.913.808 |
BIOSTRAND● Active | 0719.913.907 |
Clinitude● Active | 0478.640.857 |
C-Path● Active | 0762.683.482 |
FOx Biosystems● Bankrupt | 0653.744.366 |
Highstar Engineering● Active | 0685.983.703 |
IDEA FAMILY● Active | 0719.674.177 |
NanoBiotech● Active | 1023.651.490 |
Presscuff● Active | 0800.361.153 |
Reprosci Biosciences● Active | 1008.398.241 |
Sealantium Medical Belgium● Active | 1012.599.727 |
| 1011.224.604 | |
StingOrg● Active | 0804.587.383 |
Financials
Annual accounts
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Micro model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 20/08/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 17 months |
| Filing date | 23/07/2025 | 29/07/2024 | 30/07/2023 | 03/07/2022 | 08/07/2021 |
| General meeting | 30/06/2025 | 29/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 30/06/2025 | 23/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 29/06/2024 | 29/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 30/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 03/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 08/07/2021 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2024 · 6 active · 12 ended
Active mandates
Active
Active
Active
Active
Active
Nicolas Vandermarliere
ActiveEnded mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Capital / shares13/03/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates05/01/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates05/09/2025ONTSLAGEN - BENOEMINGEN
- Other02/09/2024DIVERSEN
- Mandates20/10/2023KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates15/04/2022ONTSLAGEN - BENOEMINGEN
- Mandates03/02/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Other03/11/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-986,9 k €↓
- 2023Annual accounts 2023-453,2 k €↑
- 2022Annual accounts 2022-768,1 k €↓
- 2021Annual accounts 2021-370,8 k €↓
- 2020Annual accounts 2020335,4 k €
- 20/08/2019IncorporationPublic limited company